Billing Requirements for Positron Emission Tomography (PET) Scans for Dementia and Neurodegenerative Diseases
This instruction updates Pub. 100-04, chapter 13, section 60, to include billing and claims processing requirements for PET Scans for beneficiaries with either a differential diagnosis of fronto-temporal dementia (FTD) and Alzheimer’s disease (AD) OR; its use in a CMS-approved practical clinical trial focused on the utility of FDG-PET in the diagnosis or treatment of dementing neurodegenerative diseases.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: October 01, 2004
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.